Feasibility Testing of Plant-Based Supplemented Food Products Made With Manitoba Crop Ingredients for Weight Loss

ConditionWeight Loss
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Manitoba

About this trial

The purpose of this study is to advance the development of the WI/CDIC supplemented foods by evaluating the acceptance and feasibility of the supplemented food bars within the Wellness Institute's Weight Loss Clinic program (WLC) or an equivalent weight loss program in Winnipeg or the surrounding area. The main questions it aims to answer are:

* To determine whether the incorporation of WI/CDIC supplemented foods into the WI weight loss clinic design is feasible. * To determine whether weight loss is supported by a plant-based supplemented food. * To assess efficacy of the supplemented food by measuring changes in lifestyle behaviours and risk factors for chronic disease compared to non-supplemented food weight loss program members.

Researchers will compare the WLC program plus supplemented food to the WLC program without the supplemented food to evaluate the implementation of the supplemented foods into the WLC.

Participants will follow their WLC program for the initial 16 weeks, and those in the intervention group will begin their supplemented food. Participants will consume one supplemented food bar each day and will record this in the product consumption log.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Male or female, aged 18 years or above

Live within the province of MB

Ability to give written informed consent in English.

Enrolled in the Wellness Institute Weight Loss Clinic or an equivalent, approved weight loss program in Winnipeg or the surrounding area.

Disqualifiers

Female participant who is pregnant, lactating or planning pregnancy during the course of the program.

Participants with known allergies to the supplemented food ingredients

Has an active eating disorder

Trial design

Design model

Parallel

Treatments tested in this trial

  • Supplemented Food

    Dietary supplement

    These supplemented foods provide plant-based protein, fibre and fatty acids that have been shown to have health benefits related to chronic disease.

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: The WLC program plus supplemented foodActive comparator 1 intervention
Group B: The WLC program onlyNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Feasibility of incorporating the WI/CDIC supplemented foods into the WI weight loss clinic.

Feasibility will be demonstrated if the following five criteria are met: 1. Eligibility to randomization ratio is greater than 0.5, calculated as the ratio of individuals within the WI WLC program who were randomized to the trial to the number eligible to participate who were approached to participate. 2. The percentage of participants who complete the 16-week program in the supplemented food arm is equivalent (plus or minus 10%) or greater than the standard arm. 3. Follow up of greater than 85% of participant outcomes. 4. Adherence to the supplemented food intervention calculated by consumption of \>75% dispensed products as documented in the Product Consumption Log 5. Product Acceptability using an Exit Questionnaire consisting of a 9-point hedonic box scale to assess mean acceptability values of 6 or greater (like at least slightly) in 75% or more of the participants.

Time frame
End of Study (Week 16)

Secondary outcomes

1

Changes in Body Weight

Body weight will be measured in kg to the nearest 0.1 kg by an exercise professional.

Time frame
At Enrollment (Week 0) and End of Study (Week 16)
2

Changes in Waist Circumference

Waist circumference in cm will be measured to the nearest 0.1 cm at the umbilicus, between the last rib and iliac crest using a fibreglass tape measured by an exercise professional.

Time frame
At Enrollment (Week 0) and End of Study (Week 16)
3

Changes in BMI

Body Mass Index will be calculated using the formula BMI = kg/m2; where kg is the weight in kilograms and m2 is height in metres squared.

Time frame
At Enrollment (Week 0) and End of Study (Week 16)
4

Cardiovascular Assessment

Using the Framingham Risk Score, cardiovascular risk will be calculated based on age, HDL-C, total cholesterol, systolic blood pressure, smoking status, and diabetes status to determine the participant's 10-year risk of cardiovascular disease and identification of metabolic syndrome.

Time frame
At Enrollment (Week 0) and End of Study (Week 16)

Other outcomes

1

Changes in Systolic Blood Pressure

Systolic blood pressure in mmHg is measured in triplicate, on the non-dominant arm in a sitting position by an exercise professional using a validated oscillometric blood pressure monitor.

Time frame
At Enrollment (Week 0) and End of Study (Week 16)
2

Changes in Diastolic Blood Pressure

Diastolic blood pressure in mmHg is measured in triplicate, on the non-dominant arm in a sitting position by an exercise professional using a validated oscillometric blood pressure monitor.

Time frame
At Enrollment (Week 0) and End of Study (Week 16)
3

Changes in Heart Rate

Heart rate in beats per minute is measured in triplicate, on the non-dominant arm in a sitting position by an exercise professional using a validated oscillometric blood pressure monitor.

Time frame
At Enrollment (Week 0) and End of Study (Week 16)
4

Changes in Physical Activity

Measured using the International Physical Activity Questionnaire - Short Form - (IPAQ-S)

Time frame
At Enrollment (Week 0) and End of Study (Week 16)

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Manitoba

Lead sponsor

Seven Oaks Hospital Chronic Disease Innovation Centre

Collaborator

The Wellness Institute

Collaborator

Government of Canada - Agriculture and Agri-Food Canada

Collaborator

This trial is not recruiting at the moment. You can still explore other options: